Patient-reported outcomes from patients with Waldenstrom macroglobulinemia treated with ibrutinib-rituximab: Results from iNNOVATE study Meeting Abstract
| Authors: | Matous, J. V.; Tedeschi, A.; Dimopoulos, M. A.; Trotman, J.; Garcia-Sanz, R.; Macdonald, D.; Mahe, B.; Herbaux, C.; Heffner, L.; Tam, C. S.; Varettoni, M.; Palomba, M. L.; Shustik, C.; Kastritis, E.; Treon, S. P.; Li, J.; Poulsen, E. G.; Hauns, B.; Buske, C.; Leblond, V. |
| Abstract Title: | Patient-reported outcomes from patients with Waldenstrom macroglobulinemia treated with ibrutinib-rituximab: Results from iNNOVATE study |
| Meeting Title: | 2019 Lymphoma and Myeloma Congress |
| Journal Title: | American Journal of Hematology |
| Volume: | 94 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2019 Oct 23-26 |
| Meeting Location: | New York, NY |
| ISSN: | 0361-8609 |
| Publisher: | John Wiley & Sons, Inc. |
| Date Published: | 2019-11-01 |
| Start Page: | S14 |
| End Page: | S15 |
| Language: | English |
| ACCESSION: | WOS:000491489200020 |
| PROVIDER: | wos |
| PUBMED: | 31621937 |
| DOI: | 10.1002/ajh.25639 |
| Notes: | Meeting Abstract: P-019 -- Source: Wos |
